eisai co ltd (4523:Tokyo Stock Exchange)
Chief Executive Officer, Representative Corporate Officer and Director, Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Mr. Haruo Naito has been Chief Executive Officer of Eisai Co. Ltd. at Eisai, Inc. since June 2003 and serves as its Representative Corporate Officer. Mr. Naito has been President of Genox Research, Inc. since March 1996 and Drug Delivery System Institute, Ltd. since June 2003. He joined Eisai Co. Ltd. in October 1975 and became its Managing Director in June 1985; Representative Director and Senior Managing Director in June 1986; and Deputy President in June 1987. He ...
4-6-10, KoishikawaPhone: 81 3 3817 3700
Tokyo, Tokyo 112-8088
Board Members Memberships*
Chief Executive Officer, Representative Corporate Officer and Director
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Bonney B.A.||Chief Executive Officer and Director|
Cubist Pharmaceuticals Inc.
|Carolyn J. Logan||Chief Executive Officer, President and Director|
Salix Pharmaceuticals Ltd.
|Akira Kurokawa||Chief Executive Officer, President and Director|
Santen Pharmaceutical Co. Ltd.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee|
|Richard Martin Steeves BSc., Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|823.0K GBP||Compensation as of Fiscal Year 2013.|